ISABELLA PANFOLI1,*, MAURIZIO BRUSCHI2, GIOVANNI CANDIANO2
BIOCELL, Vol.46, No.10, pp. 2167-2176, 2022, DOI:10.32604/biocell.2022.020154
- 13 June 2022
Abstract Precision medicine is based on the identification of biomarkers of tumor development and progression. Liquid
biopsy is at the forefront of the ability to gather diagnostic and prognostic information on tumors, as it can be
noninvasively performed prior or during treatment. Liquid biopsy mostly utilizes circulating tumor cells, or free DNA,
but also exosomes. The latter are nanovesicles secreted by most cell types, found in any body fluid that deliver
proteins, nucleic acids and lipids to nearby and distant cells with a unique homing ability. Exosomes function in
signalling between the tumor microenvironment and the… More >
Login
Register
